Elizabeth Barrett Net Worth & Insider Trades

Elizabeth Barrett - Chief Executive Officer, Urogen Pharma Ltd

As of February 2, 2023

What is Elizabeth Barrett's Net Worth?

The current estimated net worth of Urogen Pharma Ltd's Chief Executive Officer, Elizabeth Barrett, is estimated to be about $1.42M . Elizabeth Barrett owns about 308,358 units of Urogen Pharma Ltd common stock. In the last 4 years at Urogen Pharma Ltd, Elizabeth Barrett has sold an estimated value of $551.84K worth.

What is Elizabeth Barrett's Past Insider Trading?

Elizabeth Barrett's largest purchase order was 7,530 units , worth over $210.84K on November 22, 2019. Elizabeth Barrett's largest sale order was 46,968 units , worth over $429.76K on January 7, 2022. In total, Elizabeth Barrett has made about 14 transactions over 4 years of their time at Urogen Pharma Ltd. Elizabeth Barrett usually trades in February, with the busiest year in 2020. The most recent transaction was a sale order of 8,195 units , worth over $62.12K on February 2, 2022.

Elizabeth Barrett

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Elizabeth Barrett's Salary in 2020?

As Chief Executive Officer of Urogen Pharma Ltd, Elizabeth Barrett has a total base salary of $636,987 . Elizabeth Barrett received compensation valued at about $2,466,667 in 2020 after becoming Chief Executive Officer. The vast majority of their compensation came in the form of a bonus of $0 , stock awards of $441,150 , option awards of $876,164 , other earnings, plans or compensations of $468,650 , and other compensation of $43,716 .

What is Elizabeth Barrett's' Mailing Address?

  • Mailing address is C/o Urogen Pharma Ltd. 9 Ha'Ta'Asiya Street Ra'Anana L3 4365007 Israel

Urogen Pharma Ltd Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Elizabeth Barrett 2020 $636,987 $0 $441,150 $876,164 $468,650 $43,716 $2,466,667
Elizabeth Barrett 2019 $694,697 $300,000 $15,082,782 $8,979,216 $840,000 $4,128 $25,900,823
Molly Henderson 2020 $94,269 $100,000 $294,900 $787,994 $69,875 $15,192 $1,362,230
Peter P. Pfreundschuh 2020 $324,329 $0 $176,460 $292,055 $218,800 $152,313 $1,163,956
Peter P. Pfreundschuh 2019 $435,625 $0 $212,500 $436,108 $261,375 $1,183 $1,346,791
Peter P. Pfreundschuh 2018 $156,424 $0 $527,875 $1,704,505 $96,800 $197 $2,485,800
Stephen L. Mullennix 2020 $139,311 $0 $88,230 $292,055 $140,200 $246,581 $906,376
Stephen L. Mullennix 2019 $435,625 $0 $212,500 $436,108 $261,375 $904 $1,346,512
Stephen L. Mullennix 2018 $359,754 $70,000 $1,102,893 $2,552,946 $223,400 $575 $4,309,568
Mark Schoenberg 2020 $185,026 $0 $176,460 $292,054 $293150 $1,767 $948,458
Mark Schoenberg 2019 $205,000 $0 $106,250 $218,054 $270,000 $1,604 $800,908
Mark Schoenberg 2018 $200,000 $0 $0 $0 $100,000 $0 $300,000
Jason Smith 2020 $126,930 $100,000 $491,500 $785,242 $92,083 $19,518 $1,615,274
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1668243/000156459021021330/urgn-def14a_20210607.htm

What are Urogen Pharma Ltd's Past Insider Trades?

Urogen Pharma Ltd's most recent insider trade came on February 2, 2023 by Jason D. Smith Attorney-In-Fact who sold 1,636 units worth $16.56K . In the last 6 years, insiders at Urogen Pharma Ltd have sold an estimated value of $9.79M and bought an estimated value of $3.31M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Mark Schoenberg, Chief Medical Officer,  Elizabeth Barrett, Chief Executive Officer,  and Peter Pfreundschuh, Chief Financial Officer .

UroGen Pharma Ltd. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1